Pharmaceuticals

In 1947, the privately-held multinational company Kowa Company, Ltd. of Nagoya, Japan, established its pharmaceutical division in order to research, develop, manufacture and market over-the-counter (OTC) drugs, healthcare products, prescription medicines and medical devices.

Kowa’s wide variety of prescription medicines include oral agents for the treatment of cardiovascular diseases as our specialty segments, topical agents for eye and skin, and agents affecting the digestive organs.

Find out more

Work with us

For more information on our partnership opportunities please get in touch

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Find out more

You are now leaving the kowapharmaceuticals.eu website.

This link will take you to a third party website to which our Privacy policy does not apply. You are solely responsible for your interactions with any third party website. We encourage you to read the privacy policy of every website you visit.

CONTINUE TO THIRD PARTY WEBSITE

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us






    I confirm I have read and accept the terms of the Privacy policy